Age-Related Macular Degeneration (AMD) is a leading cause of vision loss, affecting millions of people worldwide. The disease is characterized by the deterioration of the macula, a small area in the retina responsible for central vision. While there is no cure for AMD, early detection and treatment can help slow the progression of the disease and preserve vision.
Artificial Intelligence (AI) has emerged as a promising tool in the fight against AMD. AI-based systems can help identify rapidly advancing AMD and predict which patients will likely progress to late-stage AMD within two years1. This information can guide treatment decisions and help physicians determine when urgent steps are needed to slow disease progression.
AI can also help improve the accuracy of prognostic information derived from retinal imaging, such as color fundus photography. This is particularly important because identifying a patient’s prognosis using this imaging technique requires significant clinical expertise, and specialists with the expertise to interpret retinal images for prognostic information are in short supply. AI-based systems can help fill this gap and deliver accurate prognostic information to guide treatment decisions.
In addition to improving the accuracy of prognostic information, AI can also help detect AMD and other eye diseases earlier. Researchers have developed algorithms that can assess the presence of AMD and glaucoma based on existing image databases of diabetic patients. These algorithms have the potential to improve screening for AMD and other eye diseases, leading to earlier detection and treatment.
AI is also being used to turn routine eye imaging data into an asset focused on diseases such as AMD and glaucoma, but with wider applications, including diabetes and dementia. This approach has the potential to revolutionize the way we diagnose and treat eye diseases, leading to better outcomes for patients.
AI integration in the fight against AMD has the potential to improve the accuracy of prognostic information, detect AMD and other eye diseases earlier, and revolutionize the way we diagnose and treat eye diseases. While there is still much work to be done, the future looks bright for AI and its role in the fight against AMD